Identification of a Feline Leukemia Virus Variant That Can Use THTR1, FLVCR1, and FLVCR2 for Infection (cid:1)

The pathogenic subgroup C feline leukemia virus (FeLV-C) arises in infected cats as a result of mutations in the envelope (Env) of the subgroup A FeLV (FeLV-A). To better understand emergence of FeLV-C and potential FeLV intermediates that may arise, we characterized FeLV Env sequences from the primary FY981 FeLV isolate previously derived from an anemic cat. Here, we report the characterization of the novel FY981 FeLV Env that is highly related to FeLV-A Env but whose variable region A (VRA) receptor recognition sequence partially resembles the VRA sequence from the prototypical FeLV-C/Sarma Env. Pseudotype viruses bearing FY981 Env were capable of infecting feline, human, and guinea pig cells, suggestive of a subgroup C phenotype, but also infected porcine ST-IOWA cells that are normally resistant to FeLV-C and to FeLV-A. Analysis of the host receptor used by FY981 suggests that FY981 can use both the FeLV-C receptor FLVCR1 and the feline FeLV-A receptor THTR1 for infection. However, our results suggest that FY981 infection of ST-IOWA cells is not mediated by the porcine homologue of FLVCR1 and THTR1 but by an alternative receptor, which we have now identified as the FLVCR1-related protein FLVCR2. Together, our results suggest that FY981 FeLV uses FLVCR1, FLVCR2, and THTR1 as receptors. Our findings suggest the possibility that pathogenic FeLV-C arises in FeLV-infected cats through intermediates that are multitropic in their receptor use. of pathogenic FeLV-C in infected cats and potential FeLV variants/intermediates that may arise, we isolated and characterized FeLV Env sequences from a primary FeLV isolate derived from a cat with pure red cell aplasia. In this study, we report the isolation and charac-* are available from Invitrogen) were used to knock down FLVCR2 expression. To validate the specificity of the FLVCR2 siRNAs, CHO cells expressing HA-tagged huFLVCR1 or huFLVCR2 were seeded (1 (cid:2) 10 5 ) in a 12-well plate. The next day, cells were transfected with 100 pmol of S1 or S2 or with control scrambled siRNA (Invitrogen) using a Lipofectamine RNAi Max kit (Invitrogen). Transfected cells were incubated for a further 2 days before preparation of cell lysates and analysis of HA-tagged FLVCR1 and FLVCR2 protein expression by Western blotting (see above). Porcine ST-IOWA cells expressing scrambled, S1, or S2 siRNA were generated by transfection of ST-IOWA cells with 100 pmol of siRNA oligonucleotides. At 2 days posttransfection, cells were infected with serial dilutions of (cid:5) -galactosidase encoding FY981 pseudotype virus, and infected cells were stained 2 days later as described above. Nucleotide sequence accession numbers. The FY981 FeLV Env and poFLVCR1, poFLVCR2, and poTHTR1 cDNA and protein sequences have been deposited in the GenBank database under accession numbers FJ436991, FJ436992, FJ436993, and FJ436994, respectively.

[1]  J. Dick,et al.  Enhanced alternative splicing of the FLVCR1 gene in Diamond Blackfan anemia disrupts FLVCR1 expression and function that are critical for erythropoiesis , 2008, Haematologica.

[2]  B. Willett,et al.  A single site for N-linked glycosylation in the envelope glycoprotein of feline immunodeficiency virus modulates the virus-receptor interaction , 2008, Retrovirology.

[3]  J. Abkowitz,et al.  A Heme Export Protein Is Required for Red Blood Cell Differentiation and Iron Homeostasis , 2008, Science.

[4]  J. Overbaugh,et al.  A Putative Thiamine Transport Protein Is a Receptor for Feline Leukemia Virus Subgroup A , 2006, Journal of Virology.

[5]  C. Tailor,et al.  Comprehensive Mapping of Receptor-Functioning Domains in Feline Leukemia Virus Subgroup C Receptor FLVCR1 , 2006, Journal of Virology.

[6]  M. Sitbon,et al.  Human T Cell Leukemia Virus Envelope Binding and Virus Entry Are Mediated by Distinct Domains of the Glucose Transporter GLUT1* , 2005, Journal of Biological Chemistry.

[7]  J. Abkowitz,et al.  Identification of a Human Heme Exporter that Is Essential for Erythropoiesis , 2004, Cell.

[8]  V. Ganapathy,et al.  SLC19: the folate/thiamine transporter family , 2004, Pflügers Archiv.

[9]  D. Lavillette,et al.  Cell surface receptors for gammaretroviruses. , 2003, Current topics in microbiology and immunology.

[10]  R. K. Murthy,et al.  Reassessing the Role of Region A in Pit1-Mediated Viral Entry , 2002, Journal of Virology.

[11]  J. Overbaugh,et al.  Receptors and Entry Cofactors for Retroviruses Include Single and Multiple Transmembrane-Spanning Proteins as well as Newly Described Glycophosphatidylinositol-Anchored and Secreted Proteins , 2001, Microbiology and Molecular Biology Reviews.

[12]  J. Overbaugh,et al.  Identification of Envelope Determinants of Feline Leukemia Virus Subgroup B That Permit Infection and Gene Transfer to Cells Expressing Human Pit1 or Pit2 , 2001, Journal of Virology.

[13]  C. Tailor,et al.  Cellular and Species Resistance to Murine Amphotropic, Gibbon Ape, and Feline Subgroup C Leukemia Viruses Is Strongly Influenced by Receptor Expression Levels and by Receptor Masking Mechanisms , 2000, Journal of Virology.

[14]  J Overbaugh,et al.  Identification of a cellular cofactor required for infection by feline leukemia virus. , 2000, Science.

[15]  J Overbaugh,et al.  Cloning of the cellular receptor for feline leukemia virus subgroup C (FeLV-C), a retrovirus that induces red cell aplasia. , 2000, Blood.

[16]  J. Farber,et al.  Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. , 1999, Annual review of immunology.

[17]  J Overbaugh,et al.  The host range and interference properties of two closely related feline leukemia variants suggest that they use distinct receptors. , 1998, Virology.

[18]  I. Paulsen,et al.  Major Facilitator Superfamily , 1998, Microbiology and Molecular Biology Reviews.

[19]  J. Albert,et al.  Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype , 1997, Journal of virology.

[20]  A. Trkola,et al.  Neutralization of the human immunodeficiency virus type 1 primary isolate JR-FL by human monoclonal antibodies correlates with antibody binding to the oligomeric form of the envelope glycoprotein complex , 1997, Journal of virology.

[21]  R. Connor,et al.  Change in Coreceptor Use Correlates with Disease Progression in HIV-1–Infected Individuals , 1997, The Journal of experimental medicine.

[22]  Marc Parmentier,et al.  A Dual-Tropic Primary HIV-1 Isolate That Uses Fusin and the β-Chemokine Receptors CKR-5, CKR-3, and CKR-2b as Fusion Cofactors , 1996, Cell.

[23]  Y Takeuchi,et al.  High-titer packaging cells producing recombinant retroviruses resistant to human serum , 1995, Journal of virology.

[24]  A. Kingsman,et al.  A transient three-plasmid expression system for the production of high titer retroviral vectors. , 1995, Nucleic acids research.

[25]  C. Barbas,et al.  Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120 , 1995, Journal of virology.

[26]  J. Neil,et al.  Virus neutralization reveals antigenic variation among feline immunodeficiency virus isolates. , 1994, The Journal of general virology.

[27]  R. Sheets,et al.  Recombinant feline leukemia virus genes detected in naturally occurring feline lymphosarcomas , 1993, Journal of virology.

[28]  J. Neil,et al.  Partial dissociation of subgroup C phenotype and in vivo behaviour in feline leukaemia viruses with chimeric envelope genes. , 1992, The Journal of general virology.

[29]  J. Mullins,et al.  Feline leukemia virus subgroup C phenotype evolves through distinct alterations near the N terminus of the envelope surface glycoprotein. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Y Takeuchi,et al.  Feline leukemia virus subgroup B uses the same cell surface receptor as gibbon ape leukemia virus , 1992, Journal of virology.

[31]  A. Miller,et al.  Tunicamycin treatment of CHO cells abrogates multiple blocks to retrovirus infection, one of which is due to a secreted inhibitor , 1992, Journal of virology.

[32]  E A Hoover,et al.  Feline leukemia virus infection and diseases. , 1991, Journal of the American Veterinary Medical Association.

[33]  O. Danos,et al.  Retroviral-mediated gene transfer into hepatocytes in vivo. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[34]  J. Mullins,et al.  Viral genetic determinants of T-cell killing and immunodeficiency disease induction by the feline leukemia virus FeLV-FAIDS , 1991, Journal of virology.

[35]  J. Abkowitz,et al.  Retrovirus-induced feline pure red blood cell aplasia: pathogenesis and response to suramin. , 1991, Blood.

[36]  J. Neil,et al.  Feline leukaemia virus: generation of pathogenic and oncogenic variants. , 1991, Current topics in microbiology and immunology.

[37]  J. Mullins,et al.  Induction of aplastic anemia by intra-bone marrow inoculation of a molecularly cloned feline retrovirus. , 1989, Leukemia research.

[38]  J. Mullins,et al.  Transduction of endogenous envelope genes by feline leukaemia virus in vitro , 1988, Nature.

[39]  J. Mullins,et al.  Molecular cloning of a feline leukemia virus that induces fatal immunodeficiency disease in cats. , 1988, Science.

[40]  C. K. Grant,et al.  Retrovirus-induced feline pure red cell aplasia. Hematopoietic progenitors are infected with feline leukemia virus and erythroid burst-forming cells are uniquely sensitive to heterologous complement. , 1987, The Journal of clinical investigation.

[41]  J. Mullins,et al.  Molecular analysis and pathogenesis of the feline aplastic anemia retrovirus, feline leukemia virus C-Sarma , 1986, Journal of virology.

[42]  J. Mullins,et al.  Nucleotide sequences of a feline leukemia virus subgroup A envelope gene and long terminal repeat and evidence for the recombinational origin of subgroup B viruses , 1986, Journal of virology.

[43]  D. Onions,et al.  Interaction between feline leukaemia virus subgroups in the pathogenesis of erythroid hypoplasia , 1984, International journal of cancer.

[44]  D. Onions,et al.  Selective effect of feline leukaemia virus on early erythroid precursors , 1982, Nature.

[45]  O. Jarrett,et al.  Determinants of the host range of feline leukaemia viruses. , 1973, The Journal of general virology.

[46]  P S Sarma,et al.  Subgroup classification of feline leukemia and sarcoma viruses by viral interference and neutralization tests. , 1973, Virology.